JC
Jason Coats
Associate Director at Churchill Capital Company,
View Jason's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Mar 2021 - Present · 3 years and 9 months
Associate Director
Jan 2022 - Present · 2 years and 11 months
Intern
Mar 2021 - Dec 2021 · 9 months
Professional Baseball Player
Jan 2017 - Oct 2019 · 2 years and 9 months
Company Details
Churchill Capital Company is a Real Estate Investment Banking and Principal Investments firm that prides itself on its profound knowledge of the real estate capital markets and its steadfast stewardship of partner capital. Since its inception in 1995, Churchill Capital Company has arranged over $9 billion in debt and equity placements for its clients and participated in debt and equity investments on transactions totaling over $200 million. Churchill Capital Company represents developers, owners and investors in securing debt and equity capital at the property and corporate level. Our clients rely on us for rapid closings, certainty of execution and the most competitive terms on the market. Over 80% of our business is conducted with repeat clients. Churchill Capital Company's track record spans all property types and financial products, with over 500 commercial real estate transactions ranging in size from $2 to $500 million. Churchill Capital Company’s Principal Investments typically range from $1 million to $10 million in size and include all major commercial real estate property types located throughout the United States. Principal Investments (debt and equity) total in excess of 14 million square feet and represent over $200 million in transaction value.
Year Founded
1995
Social Media
LinkedinTwitter
Industry
Investment Banking
HQ Location
2727 LBJ Freeway Suite 600 Dallas, TX 75234, US
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Jason Coats in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.